{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:51:18Z","timestamp":1790401878304,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.mehy.2007.06.030","type":"journal-article","created":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T08:56:51Z","timestamp":1187686611000},"page":"548-550","source":"Crossref","is-referenced-by-count":27,"title":["Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1"],"prefix":"10.1016","volume":"70","author":[{"given":"Shih-Jen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2007.06.030_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol Psych"},{"issue":"Suppl. 16","key":"10.1016\/j.mehy.2007.06.030_bib2","first-page":"10","article-title":"The definition and meaning of treatment-resistant depression","volume":"62","author":"Sackeim","year":"2001","journal-title":"J Clin Psych"},{"key":"10.1016\/j.mehy.2007.06.030_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0169-328X(00)00263-1","article-title":"Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery","volume":"86","author":"Medhurst","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.mehy.2007.06.030_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0006-3223(99)00177-8","article-title":"Eural plasticity to stress and antidepressant treatment","volume":"46","author":"Duman","year":"1999","journal-title":"Biol Psych"},{"key":"10.1016\/j.mehy.2007.06.030_bib5","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/sj.emboj.7600234","article-title":"TREK-1, a K+ channel involved in neuroprotection and general anesthesia","volume":"23","author":"Heurteaux","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.mehy.2007.06.030_bib6","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1038\/sj.emboj.7601116","article-title":"TREK-1, a K+ channel involved in polymodal pain perception","volume":"25","author":"Alloui","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.mehy.2007.06.030_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn2117","article-title":"The neuronal background K2P channels: focus on TREK1","volume":"8","author":"Honore","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2007.06.030_bib8","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/nn1749","article-title":"Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype","volume":"9","author":"Heurteaux","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mehy.2007.06.030_bib9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nn0906-1081","article-title":"TREKing toward new antidepressants","volume":"9","author":"Gordon","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mehy.2007.06.030_bib10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bjp.0706068","article-title":"Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine","volume":"144","author":"Kennard","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2007.06.030_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1527-3458.2000.tb00141.x","article-title":"Sipatrigine (BW 619C89) is a neuroprotective agent and a sodium channel and calcium channel inhibitor","volume":"6","author":"Hainsworth","year":"2000","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.mehy.2007.06.030_bib12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.STR.24.7.1063","article-title":"BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage","volume":"24","author":"Leach","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2007.06.030_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0006-8993(00)03239-X","article-title":"The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK","volume":"892","author":"Meadows","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2007.06.030_bib14","first-page":"846","article-title":"Bipolar depression: an overview","volume":"7","author":"Oral","year":"2004","journal-title":"IDrugs"},{"key":"10.1016\/j.mehy.2007.06.030_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1017\/S1092852900010324","article-title":"Lamotrigine augmentation strategy for patients with treatment-resistant depression","volume":"10","author":"Gutierrez","year":"2005","journal-title":"CNS Spectr"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2007.06.030_bib16","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","article-title":"Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments","volume":"7","author":"Krystal","year":"2002","journal-title":"Mol Psych"},{"key":"10.1016\/j.mehy.2007.06.030_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2006.04.037","article-title":"Antidepressant-like effects of ceftriaxone in male C57BL\/6J mice","volume":"61","author":"Mineur","year":"2007","journal-title":"Biol Psych"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707004562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707004562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T20:57:02Z","timestamp":1546635422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987707004562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0306987707004562"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2007.06.030","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}